- Journal Home
- Volume 22 - 2025
- Volume 21 - 2024
- Volume 20 - 2023
- Volume 19 - 2022
- Volume 18 - 2021
- Volume 17 - 2020
- Volume 16 - 2019
- Volume 15 - 2018
- Volume 14 - 2017
- Volume 13 - 2016
- Volume 12 - 2015
- Volume 11 - 2014
- Volume 10 - 2013
- Volume 9 - 2012
- Volume 8 - 2011
- Volume 7 - 2010
- Volume 6 - 2009
- Volume 5 - 2008
- Volume 4 - 2007
- Volume 3 - 2006
- Volume 2 - 2005
- Volume 1 - 2004
Cited by
- BibTex
- RIS
- TXT
We explore methods to automatically detect the quality in individual or batches of pharmaceutical products as they are manufactures. The goal is to detect 100% of the defects, not just statistically sample a small percentage of the products and draw conclusions that may not be 100% accurate. Removing all of the defective products, or halting production in extreme cases, will reduce costs and eliminate embarrassing and expensive recalls. We use the knowledge that experts have accumulated over many years, dynamic data derived from networks of smart sensors using both audio and chemical spectral signatures, multiple scales to look at individual products and larger quantities of products, and finally adaptive models and algorithms.
}, issn = {2617-8710}, doi = {https://doi.org/}, url = {http://global-sci.org/intro/article_detail/ijnam/618.html} }We explore methods to automatically detect the quality in individual or batches of pharmaceutical products as they are manufactures. The goal is to detect 100% of the defects, not just statistically sample a small percentage of the products and draw conclusions that may not be 100% accurate. Removing all of the defective products, or halting production in extreme cases, will reduce costs and eliminate embarrassing and expensive recalls. We use the knowledge that experts have accumulated over many years, dynamic data derived from networks of smart sensors using both audio and chemical spectral signatures, multiple scales to look at individual products and larger quantities of products, and finally adaptive models and algorithms.